Efficacy and safety of oral alitretinoin in severe oral lichen planus – results of a prospective pilot study

Abstract

Alitretinoin given at 30 mg daily reduced disease severity of severe oral lichen planus in a substantial proportion of patients refractory to standard treatment, was well tolerated and may thus represent one therapeutic option for this special group of patients.